Sorin Group’s next-gen DES
This article was originally published in The Gray Sheet
Executive Summary
Firm has launched its Janus Flex tacrolimus-eluting Carbostent system in Europe, Sorin announces Feb. 21. With many of the same safety and efficacy components of the company's first-generation product - including a polymer-free design that relies on reservoirs on the stent's outer surface for targeted drug release - the firm claims Janus Flex features an improved catheter tip to facilitate deliverability and conformability in difficult-to-access anatomy...
You may also be interested in...
Sorin stent
Chrono cobalt chrome stent launches in Europe following CE mark receipt April 4. Sorin claims that in comparison to stainless steels stents, Chrono offers better mechanical strength, flexibility and radiopacity. The device features two radiopaque markers at each end to aid in placement at the target lesion as well as a bio-compatible coating to reduce stent thrombosis. In February, the firm launched the Janus Flex tacrolimus-eluting stent in Europe (1"The Gray Sheet" Feb. 27, 2006, In Brief)...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.